GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Cash per Share

Valeo Pharma (TSX:VPH) Cash per Share : C$0.07 (As of Jul. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Valeo Pharma's Cash per Share for the quarter that ended in Jul. 2024 was C$0.07.


Valeo Pharma Cash per Share Historical Data

The historical data trend for Valeo Pharma's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Cash per Share Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cash per Share
Get a 7-Day Free Trial 0.01 0.04 0.03 0.27 0.08

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.08 0.10 0.07 0.07

Valeo Pharma Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Valeo Pharma's Cash per Share for the fiscal year that ended in Oct. 2023 is calculated as:

Valeo Pharma's Cash per Share for the quarter that ended in Jul. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valeo Pharma  (TSX:VPH) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Valeo Pharma Cash per Share Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma Business Description

Traded in Other Exchanges
N/A
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Executives
Luc Mainville Senior Officer
100079 Canada Inc. 10% Security Holder
Richard J. Mackay Director, Director or Senior Officer of 10% Security Holder
Steve Saviuk Director, Director or Senior Officer of 10% Security Holder, Senior Officer
Jeffrey Michael Skinner Senior Officer
Frederic Fasano Director
Guy Paul Allard Director or Senior Officer of 10% Security Holder, Senior Officer
Marc François Léger Senior Officer

Valeo Pharma Headlines

No Headlines